Market Research Logo

Global Blood Cancer Therapeutics Market 2019-2023

Global Blood Cancer Therapeutics Market 2019-2023

About this market

Leukemia is the most common type of cancer in children and also accounts for the highest mortality rate among cancers in pediatric patients. The prevalence of leukemia has been increasing at a significantly high rate. The incidence of other types of blood cancer such as lymphomas is also another factor driving the growth of the market, as it is leading to vendors conducting research on new areas. Most of the drugs are being developed for both lymphoma and leukemia, thus leading to more vendors entering the market to research on novel therapies. The high incidence of various types of leukemia in pediatric patients is expected to be one of the major drivers of the global blood cancer therapeutics market during the forecast period. Technavio’s analysts have predicted that the blood cancer therapeutics market will register CAGR of over 8% by 2023.

Market Overview

Growing adoption of therapeutics

The increasing awareness about the disease, along with the increasing global incidence, is leading to more patients undergoing diagnosis and opting for treatment during the early stages of the disease. This is leading to the increasing adoption of therapeutics for the treatment. These factors are expected to result in the growth of the global blood cancer therapeutics market during the forecast period.

Adverse effects of stem cell transplantation

Bone marrow and stem cell transplantations are some of the most effective treatment options for the treatment of blood cancer types such as leukemia, multiple myeloma, and non-Hodgkin's lymphoma. Although the treatment using stem cells is highly effective for the treatment of cancer, the side effects associated with the treatment are often high. The threat of side effects of stem cell transplant is expected to continue posing a challenge to the market growth during the forecast period.

For the detailed list of factors that will drive and challenge the growth of the blood cancer therapeutics market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fairly fragmented and with the presence of several vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.


  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global oncology therapeutics market
      • Table Segments of global oncology therapeutics market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Pipeline
    • Table Global blood cancer therapeutics market pipeline: Overview
  • Market segmentation by type
    • Table Type - Market share 2018-2023 (%)
    • Comparison by type
      • Table Comparison by type
    • Leukemia - Market size and forecast 2018-2023
      • Table Leukemia - Market size and forecast 2018-2023 ($ millions)
      • Table Leukemia - Year-over-year growth 2019-2023 (%)
    • Lymphoma - Market size and forecast 2018-2023
      • Table Lymphoma - Market size and forecast 2018-2023 ($ millions)
      • Table Lymphoma - Year-over-year growth 2019-2023 (%)
    • Myeloma - Market size and forecast 2018-2023
      • Table Myeloma - Market size and forecast 2018-2023 ($ millions)
      • Table Myeloma - Year-over-year growth 2019-2023 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in North America
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Europe
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in Asia
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
      • Table Top 3 countries in ROW
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bristol-Myers Squibb Company
      • Table Bristol-Myers Squibb Company - Vendor overview
      • Table Bristol-Myers Squibb Company - Business segments
      • Table Bristol-Myers Squibb Company - Organizational developments
      • Table Bristol-Myers Squibb Company - Geographic focus
      • Table Bristol-Myers Squibb Company - Key offerings
      • Table Bristol-Myers Squibb Company - Key customers
    • F. Hoffmann-La Roche Ltd
      • Table F. Hoffmann-La Roche Ltd - Vendor overview
      • Table F. Hoffmann-La Roche Ltd - Business segments
      • Table F. Hoffmann-La Roche Ltd - Organizational developments
      • Table F. Hoffmann-La Roche Ltd - Geographic focus
      • Table F. Hoffmann-La Roche Ltd - Segment focus
      • Table F. Hoffmann-La Roche Ltd - Key offerings
      • Table F. Hoffmann-La Roche Ltd - Key customers
    • Johnson & Johnson Services, Inc.
      • Table Johnson & Johnson Services, Inc. - Vendor overview
      • Table Johnson & Johnson Services, Inc. - Business segments
      • Table Johnson & Johnson Services, Inc. - Organizational developments
      • Table Johnson & Johnson Services, Inc. - Geographic focus
      • Table Johnson & Johnson Services, Inc. - Segment focus
      • Table Johnson & Johnson Services, Inc. - Key offerings
      • Table Johnson & Johnson Services, Inc. - Key customers
    • Novartis AG
      • Table Novartis AG - Vendor overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Organizational developments
      • Table Novartis AG - Geographic focus
      • Table Novartis AG - Segment focus
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Key customers
    • Takeda Pharmaceutical Company Limited
      • Table Takeda Pharmaceutical Company Limited - Vendor overview
      • Table Takeda Pharmaceutical Company Limited - Business segments
      • Table Takeda Pharmaceutical Company Limited - Organizational developments
      • Table Takeda Pharmaceutical Company Limited - Geographic focus
      • Table Takeda Pharmaceutical Company Limited - Key offerings
      • Table Takeda Pharmaceutical Company Limited - Key customers
  • Appendix
    • Research methodology gy
      • Table Validation techniques employed for market sizing
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report